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Abstract 
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Date: April 2010 
Pages: 157 
 The Knoevenagel reaction is defined by the condensation of an aldehyde or 
ketone with a carbon nucleophile produced by the deprotonation of a methylene 
species whose acidity is dramatically increased by bonds to strongly electron 
withdrawing groups. Previously, our group developed an effective one-pot method for 
the preparation of 4H-chromenes using sodium borohydride reduction of the cyclized 
intermediates formed by the Knoevenagel condensation of malononitrile with 
salicylaldehydes in aqueous ethanol. In this study we outline the extension of these 
strategies to include 2’-hydoxyphenylketones as the starting material. Many of these 
compounds are also unique and were prepared by Friedel-Crafts acylation of phenols 
with acyl chlorides and/or Fries Rearrangement of the corresponding phenyl ester.
 
 
The objective of this project has been to expand the application of the methods 
optimized in our lab for the simple and efficient formation of carbon-carbon bonds via 
the selective reduction of the alkylidene portion of the Knoevenagel reaction products. 
These methods have allowed for the production of several important classes of natural 
product-like compounds. Specifically, in this investigation, we have adapted these 
methods to the production of various 4-alkyl and 4-aryl substituted 3-amino-2-cyano-
4H-chromenes. These types of molecules exhibit diverse pharmacological activity and 
have been shown to be potentially useful for the treatment of various diseases. A subset 
of the synthesized compounds will be submitted to Eli Lilly through their PD2 program. 
 Further variation of substrates included the reaction of salicylaldehydes with 
ethyl cyanoacetate or cyanoacetamide which provided products unreported in the 
literature. Reactions with cyanoacetates gave the expected 3-carboethoxy(ester) 
functionalized 4H-chromene compounds. Products from cyanoacetamide were found to 
occur in open rather than cyclized forms. 
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1.1 Introduction 
As part of the ongoing project in our laboratory investigating the carbon-carbon 
bond forming Knoevenagel reaction, it was shown that the technique could be used to 
produce a variety of interesting and potentially useful compounds. This includes 
efficient access to several fundamental heterocyclic ring systems that are of particular 
biological interest. This reaction is the condensation of an aldehyde or ketone carbonyl 
with a carbon nucleophile produced by proton abstraction of compounds that have 
form Z-CH2-Z’ or Z-CHR-Z’ where Z and Z’ may be CHO, COR, COOH, COOR, CN, NO2, SOR, 
SO2R, SO2R.
1   
       
       Scheme 1.1 General Scheme for Knoevenagel Condensation 
The methylene carbon atom of these molecules is activated by the adjoining 
electron withdrawing groups which reduce the electron density of the carbon 
sufficiently to make the C-H bond somewhat acidic and help to stabilize the resulting 
negative charge.   
1.2 Production of Monosubstituted Malononitriles 
The process was shown applicable by Sammelson and Allen for the production of 
monosubstituted malononitrile compounds by alumina catalyzed Knoevenagel reaction 
of malononitrile with n-alkylketones; and sodium borohydride reduction of the 
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alkylidene intermediate in a two step one-pot process.2  This was an improvement over 
methods  such as direct alkylation of malononitrile3a, or other condensation/reduction 
methods carried out with reducing agents like Indium metal in aqueous ethanolic 
ammonium chloride3b, indium (III) chloride with sodium borohydride in acetonitrile3c, or 
Hantzsch 1,4-dihydropyridine ester.3d In the case of direct alkylation the reaction has 
been known to over alkylate the substrate producing only the symmetrically di-
substituted malononitrile. While some condensation reduction methods use more 
expensive reagents or require involved preparation and in the case of the Hantzsch 1,4-
dihydropyridine ester suffer from lack of carbon efficiency. Further improvement was 
achieved by Dunham et. al. when they realized that sodium borohydride could be used 
as the Knoevenagel catalyst and as the reducing agent for the intermediate electron 
deficient olefin in a single step one pot process using aldehydes or ketones.4 The general 
mechanism proposed for this reaction is presented in Scheme 1.1. 
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Scheme 1.2 Proposed mechanism for one-step/one-pot condensation/reduction method 
In this mechanism, sodium borohydride acts to produce an alkoxide ion from the 
starting ketone or aldehyde which in turn deprontonates malononitrile(pka = 11.2) (or 
possibly the hydride itself deprotonates malononitrile). The carbanion then condenses 
with the carbonyl group and proton transfer and/or protonation precedes the 
elimination of water. The formed alkylidene malononitrile intermediate is an electron 
deficient olefin that reacts with hydride to give the substituted malononitrile anion (III). 
This is able to accept a proton from another malononitrile molecule, yielding the final 
product and another equivalent of the carbon nucleophile (II) to continue the process. 
The utility of this reaction was shown on a variety of alkyl ketones and aldehydes 
eventually leading to the production of benzyl substituted malononitriles from 
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benzaldehydes. Unfortunately, when these conditions were extended to aryl substrates 
the competing reduction of the aldehyde took precedence and lower yields of the 
desired product were obtained. Additionally, these alcohol side-products were no 
longer volatile and/or water soluble.   
1.3 Knoevenagel Condensation with Aryl Substrates 
The Knoevenagel condensation of these aryl aldehydes with malononitrile were 
shown to proceed in water5 or ethanol6 without other catalyst, and the reaction being 
driven toward completion by the precipitation of the product. These examples are 
represented in Scheme 1.2. 
 
Scheme 1.3 Uncatalyzed Condensation
 
This work provided the foundation for Tayyari  et. al. to develop the  one-pot method 
for the reductive alkylation of malononitrile with aromatic aldehydes, which was a vast 
improvement on other procedures giving increased efficiency and yields.7 Also the one-
pot procedure avoided the handling of hazardous intermediates as seen in entry 6 of 
Table 1.1, whose intermediate alkylidene species is known to be a lachrymator and used 
as a riot control agent. It was seen that when water was used as the solvent the reaction 
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mixture had a tendency to oil out and in absolute ethanol the reaction rate was very 
slow. The conditions were optimized by the use of a 95% ethanol/water solution at a 
concentration of 1.0M for the arylaldehyde and malononitrile. The procedure gave the 
desired products in good yields with appropriate reaction times on a variety of aryl 
substrates. These results are shown in Table 1.1.  
 
Entry Ar Product Time(h)a Yield (%)b Yield (%)c 
1 Ph 1 1 98 85 
2 4-MeOPh 2 1 94 88 
3 4-MePh 3 3.5 92 76 
4 4-BrPh 4 2 94 94 
5 4-ClPh 5 2 96 91 
6 2-ClPh 6 24 94 Xd 
7 4-NO2Ph 7 2 96 90 
8 3-NO2Ph 8 1.5 97 88 
9 2-NO2Ph 9 0.5 97 84 
10 4-HOPh 10 18 80 85 
11 3-HOPh 11 18 76 Xd 
12 4-HO-3-MeOPh 12 24 84 74 
13 2-(4-ClBnO)Ph 13 3 75 Xd 
14 4-Me2NPh 14 2.5 98 90 
15 4-(2-pyridyl)Ph 15 24 98 -e 
16 2,4,6-Cl3Ph 16 24 97 -
e 
17 2-fluorene 17 3 62 -e 
18 2,4-(MeO)2Ph 18 24 -
f 98 
19 2-(BnO)Ph 19 24 -f 87 
a Time refers to the condensation step. 
b Isolated yield of purified compound using extraction method work-up. 
c Isolated yield of purified compounds using filtration method work-up. 
d No precipitate formed and extraction method work-up must be used. 
e Filtration method work-up was not attempted. 
f Extraction method work-up was not attempted. 
Table 1.1 Reductive Alkylation of Malononitrile with Aromatic Aldehydes 
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When the two step one pot condensation/reduction procedure was performed 
on 2-hydroxybenzaldehydes (salicylaldehydes) the resulting product was not the 
expected 2’-hydroxybenzylmalononitrile. Instead it was found that an intramolecular 
cyclization occurs by the nucleophillic attack of the o-hydroxyl oxygen on one of the 
cyano carbons after the condensation, and upon reduction gave 2-amino-3-cyano-4H-
chromenes in good to high yields.7 These methods allow access to this very important 
class of compounds and efficient production of the chromene moiety is a highly 
desirable and sought after process.   
1.4 Knoevenagel Condensation with Salicylaldehydes 
 The reaction of malononitrile with salicylaldehyde has been reported to give 
several different products. In their paper Pande et al. described the condensation of 
several aromatic aldehydes with malononitrile including a 1:1 molar ratio of 
salicylaldehyde:malononitrile in water at 35 °C with 1-methylimidzole as a catalyst and 
they show an uncyclized product as the result (Scheme  1.3).8 
 
Scheme 1.4 Condensation of malononitrile with salicylaldehyde
 
  Deb et al. performed a similar reaction with a 1:1 molar ratio 
 o-hydroxybenzaldehyde:malononitrile in water without catalyst and describe the  
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product as a 2-imino-2H-1-benzopyran-3-carbonitrile.5  Zahouily et al. report the use of 
potassium fluoride-doped natural phosphate as a catalyst in methanol solvent at room 
temperature and describe a 2-amino-3-cyano-4-malononitrile-4H-chromene as the 
result.9 Elinson et al. generated malononitrile substituted 4H-chromene upon reaction 
of salicyladehyde and malononitrile in alcohols in the presence of sodium bromide as an 
electrolyte in an undivided electrocatalytic cell.10  In ethanol with a piperidine catalyst 
Volmajer et al. reported the product to be the 3-cyano-2-imino-2H-chromene.11         
 
Scheme  1.5 Catalyzed Condensation of Malononitrile with Salicylaldehyde 
        Finally, Costa et al. showed that reaction conditions dictated which product 
would be formed and careful control of these conditions allowed them to synthesize 
multiple compounds from the reaction of malononitrile and salicylaldehyde.12 Among 
the procedures was the production of the 2-imino-2H-chromene-carbonitrile using 1.7-
2.1 equivalents of malononitrile to 1 equivalent salicylaldehyde in 0.05M aqueous 
sodium bicarbonate or 0.05M aqueous sodium carbonate at room temperature for 2-24 
hours (Scheme 1.4) or alternatively the production of (2-amino-3-cyano-4H-chromen-4-
yl)malononitrile with 1.7-2.1 molar equivalents of malononitrile to 1 equivalent 
salicylaldehyde in dichloromethane or methanol with triethylamine catalyst or 1.7-2:1 
equivalents malononitrile to 1 equivalent salicylaldehye in 0.05M aqueous sodium 
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bicarbonate at room temperature for 5-40 minutes (Scheme  1.4).12 Costa also 
performed a 1H NMR study that provided a description of the intermediate products 
formed over the course of the condensation/cyclization. A depiction of their results is 
shown in Scheme 1.6.  
 
Scheme 1.6 Intermediates in the Reaction of Malononitrile with Salicylaldehyde 
Most notable among the results was the initial benzylidene malononitrile condensate 
product (A), an electron deficient olefin and good Michael acceptor, reacts a second 
equivalent of malononitrile to give the addition product (B). This yields the cyclized 
imino chromane species (C) which then tautomerizes to the enamine giving the 4-
substituted 4H-aminochromene (D) that equilibriates with the 2H-iminochromene (E) by 
the simultaneous addition/elimination of the second malononitrile equivalent.   
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1.5 One-Pot Synthesis of Substituted 4H-Chromenes                                                        
 Tayyari et al. were able to apply the one-pot procedure to the production of a 
variety of substituted 4H-chromene compounds.3 The reaction was carried out in 95% 
ethanol and it was found that 2 equivalents of malononitrile were required for good 
yields and the intermediate formed was the (2-amino-3-cyano-4H-chromen-4-
yl)malononitrile. Table 1.2 lists the results of these experiments.  
 
R
1 
R
2 
R
3 % Yield 
H H Br 91 
CH3CH2O H H 93 
Cl H Cl 87 
H H NO2 89 
CH3O H H 66 
CH3O H Br 61 
H H Cl 89 
CH=CH-CH=CH H 73 
Table 1.2 Results of One-Pot Production of 4H-Chromenes 
In two of the experiments when the salicylaldehyde was substituted with a 
strong electron donating group the reaction proceeded by an additional pathway. In 
these cases the second equivalent of malononitrile added in a different arrangement. 
The malononitrile activated methylene carbon reacted with the chromene cyano carbon 
and in turn the chromene 2-amino group reacted with a malononitrile nitrile carbon 
through another cyclization process giving the corresponding substituted 
11 
 
benzopyranopyridine. These types of compounds are also of great interest and methods 
for their preparation are of importance. This reaction sequence can be seen in Scheme 
1.7.3   
 
Scheme 1.7 Substituted Benzopyranopyridenes 
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2.1 Introduction 
 For the production of our 4H-chromene target molecules it was found that many 
of the 2’-hydroxyphenylketone precursor compounds were not readily available through 
commercial sources. These starting materials were prepared by the application of 
literature methods for Friedel-Crafts acylation and Fries rearrangemant of the 
corresponding phenol and acyl substrates or by palladium catalyzed coupling of 
salicylaldehydes with iodoarenes.  
2.2 Other Applications of Benzophenones 
 It is worth noting that benzophenone analogues have been well documented as 
chemotherapeutic agents especially for anti-inflammatory applications.35 Recently 
molecules containing the benzophenone core were reported to be a novel class of p38 
MAP kinase inhibitors with high anti-inflammatory activity and are shown in Figure 
2.1.21 Several classes of hydroxyl substituted benzophenones have been pursued and 
have shown promise as potential medicinal products. 
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Figure 2.1 Anti-inflammatory benzophenones 
 
2.3 Literature Methods for the Preparation of 2’-Hydroxyphenylketones 
Among the various methods typically used to prepare aryl ketones, Friedel-Crafts 
acylation reactions are the most important. This reaction employs a Lewis acid catalyst 
(usually aluminum chloride) and often an acyl halide, although other reagents have 
been applied such as carboxylic acids, anhydrides, and ketenes.1 A common variation 
used particularly for the ortho acylation of phenols is referred to as the Fries 
rearrangement36 and involves the esterification of the phenol hydroxyl group before 
treatment with aluminum chloride. It is often reported that carrying out the Fries 
Rearrangement at high temperature produces an increased ratio of the ortho 
substituted product.36 (Scheme 2.1).37 
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Scheme 2.1 Fries Rearrangement of p-nitrophenol
 
Numerous examples of the Fries Rearrangement can be found in the literature 
with many different variations using several different reagents. It has been reported 
frequently that as the acyl group becomes larger and more sterically hindered the para 
product becomes increasingly prevalent.24 To overcome this problem Miller utilized a 
lithiation procedure to direct acyl migration primarily to the ortho position.24 This metal 
promoted variation is known as the anionic Fries rearrangement (Scheme 2.2).   
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                                              Scheme 2.2 Metal promoted Fries Rearrangement 
              Satoh et al. were able to efficiently produce 2-hydroxybenzphenones by the 
direct coupling of salicylaldehydes and iodobenzene, using palladium(II) chloride as a 
catalyst in the presence of lithium chloride.25  This reaction can be seen in Scheme 2.3.                                    
 
Scheme 2.3 Palladium Catalyzed Coupling of Salicylaldehydes with Aryl Iodides
 
2.4 Results and Discussion 
 It was often observed that while following the general procedure for the Fries 
rearrangement consistently the product obtained was approximately a 50:50 mixture of 
the ortho / para isomers. The optimized procedure used most often simply involved the 
addition of the acid chloride directly to the phenol without prior efforts to ensure 
esterification. The isomers were often separated by exploiting their respective solubility 
in hexane (the ortho isomer proved much more nonpolar due to intramolecular 
17 
 
hydrogen bonding). Ultimately the most frequently used procedure was the Friedel-
Crafts / Fries reaction for its ability to produce both alkyl and aryl ketones and general 
availability of starting materials. The coupling of salicylaldehydes with aryl iodides was 
quite efficient and produced the desired benzophenone derivatives without any 
unwanted isomers. This reaction was apparently limited to the formation of 
benzophenones and access to novel salicylaldehydes and aryl iodides was somewhat 
limited. The materials produced are listed in Table 2.1. 
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R1 R2 R3 R4 Product Time (h) Yield 
Propyl H H H 1 2 33 
Propyl Methyl H H 2 2 79 
i-propyl H H H 3 2 42 
i-butyl H H H 4 2 47 
Neopentyl H H H 6 1.75 47 
1-ethylpropyl H H H 7 2 44 
Phenyl H Methyl H 8 2 38 
Phenyl Bromo H H 9 2 91 
4-fluorophenyl Methyl H H 10 2 75 
2-furanyl Methyl H H 11 2 73 
Phenyl H H Ethoxy 12 8 82a 
Phenyl Chloro H H 13 6 56a 
a Product produced by palladium coupling procedure method 
    Table 2.1 2’-Hydroxyphenylketones 
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2.5 General Experimental  
Analytical thin-layer chromatography (TLC) was performed using Baker-Flex silica 
gel IB-F plates and visualized using UV lamp and basic KMnO4 (2.3 g KMnO4, 15 g K2CO3, 
1.9 mL 2.5M NaOH in 300 mL DI H2O). Column chromatography was performed using 
silica gel (35-70mm, 6nm pore) from Acros. Infrared spectra were recorded on a Perkin-
Elmer Spectrum 100 FT-IR spectrometer using an ATR accessory with a diamond 
element. Proton nuclear magnetic resonance (1H NMR) spectra and carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded on a JEOL Eclipse spectrometer at 
400 MHz or 300 MHz and 100 or 75 MHz, respectively. Chemical shifts are reported 
downfield from referenced values for CDCl3 (
1H NMR = 7.26ppm, 13C = 77.16 ± 
0.06ppm).19 Purchased chemicals were used without further purification; prepared 
materials were purified by column chromatography or recrystallization prior to use. 
Representative procedure for Friedel-Crafts Acylation / Fries Rearrangement 
15 mmol of phenol was added to a round bottom flask followed by 15 mmol of 
acid chloride and then 22.5 mmol aluminum chloride. The mixture was heated at 140-
160 °C for 2 hours and cooled to room temperature. 15 mL of 6M HCl was added to the 
glassy solid and the resultant solution was heated to boiling to complete hydrolysis. The 
mixture was extracted with hexanes (3x20 mL) the extracts were combined, dried over 
magnesium sulfate and stripped of solvent under vacuum. If necessary, the product was 
purified by recrystallization from ethanol or by column chromatography.                                                                              
20 
 
General Procedure for Preparation of Acyl Chlorides 
When only the carboxylic acid was available the corresponding acid chloride was 
produced immediately prior to use by adding 1.2 molar equiv. of thionyl chloride and 
heating to 70°C for 45min.26 
Representative Procedure for the Direct Coupling of Salicyladehydes with 
Iodobenzene25 
 To a solution of 3-ethoxysalicylaldehyde (1 mmol) and iodobenzene (2 mmol) 
was added PdCl2 (0.05 mmol) followed by LiCl (0.2 mmol) then Na2CO3 (2 mmol) and 
finally anhydrous DMF (5 mL). The mixture was heated at 100 °C for 8 hours or until 
complete as indicated by TLC. The solids were filtered out and 25 mL DI H2O was added. 
This solution was extracted 3 times with CH2Cl2 and the extracts were combined and 
thoroughly washed with DI H20 to remove traces of DMF, dried over magnesium sulfate, 
and concentrated under vacuum. This crude product was purified by column 
chromatography.  
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2.6 Data 
2-butanoylphenol (1) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using phenol (1.44g, 15.3 mmol), butyryl chloride (1.64g, 15.0 mmol), and aluminum 
chloride (2.91g, 22.5mmol); yielded a yellow oil (0.88g, 36%). 1H NMR (300MHz, 
CHLOROFORM-d) δ 12.41 (s, 1H), 7.77 (d, J = 8.0 Hz, 1H), 7.46 (t, J = 7.7Hz, 1H), 6.98 (d, J 
= 8.5 Hz, 1H), 6.89 (t, J = 7.5Hz, 1H), 2.97 (t, J = 7.4 Hz, 2H), 1.79 (sex, J = 7.4 Hz, 2H), 1.03 
(t, J = 7.4 Hz, 3H). 13C (75MHz, CHLOROFORM-d) δ 206.7, 162.4, 136.1, 129.9, 119.3, 
118.8, 118.4, 17.8, 13.7.  
2-butanoyl-4-methylphenol (2) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using p-cresol (0.54 g, 5.0 mmol), butyryl chloride (0.59 g, 5.5 mmol), and aluminum 
chloride (1.00 g, 7.5 mmol); yielded an off white solid (0.70 g, 79%). 1H NMR (300MHz, 
CHLOROFORM-d) δ 12.23 (s, 1H), 7.53 (s, 1H), 7.28 (d, J = 8.2 Hz, 1H), 6.88 (d, J = 8.5 Hz, 
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1H), 2.96 (t, J = 7.4 Hz, 2H), 2.31 (s, 3H), 1.78 (sex, J = 7.4 Hz, 2H), 1.02 (t, J = 7.4 Hz, 
3H).13C (75MHz, CHLOROFORM-d) δ 206.6, 160.4, 137.1, 129.7, 127.8, 119.0, 118.2, 
40.1, 20.5, 17.8, 13.8. 
2-isobutanoylphenol (3) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using phenol (2.02 g, 11.5 mmol), isobutyryl  chlroride (1.10 g, 10.3 mmol), and 
aluminum chloride (1.6 g, 12.0 mmol); yielded pale yellow oil (1.46 g, 42%). 1H NMR 
(300MHz, CHLOROFORM-d) δ 12.53 (s, 1H), 7.79 (d, J = 8.0 Hz, 1H), 7.46 (t, J = 8.5 Hz, 
1H), 6.99 (d, J = 7.4 Hz, 1H), 6.90 (t, J = 8.0 Hz, 1H), 3.62 (sep, J = 6.9 Hz, 1H), 1.26 (d, J = 
6.9 Hz, 6H). 13C (75MHz, CHLOROFORM-d) δ 210.8, 162.9, 136.1, 129.8, 118.8, 118.5, 
118.0, 115.2, 34.8, 19.2. 
2-isovaleroylphenol (4) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using phenol (1.76 g, 18.7 mmol), isovaleryl chloride (2.10 g, 17.6 mmol), and aluminum 
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chloride (2.90 g, 22.5 mmol); yielded a pale yellow oil (1.49 g, 47%). 1H NMR (300MHz, 
CHLOROFORM-d) δ 12.48 (s, 1H), 7.76 (d, J = 9.63 Hz, 1H), 7.46 (t, J = 8.52 Hz, 1H), 6.99 
(d, J = 9.6 Hz, 1H), 6.89 (t, J = 8.3 Hz, 1H), 2.85 (d, J = 6.9 Hz, 2H), 2.30 (sep, J = 6.9 Hz, 
1H), 1.02 (d, J = 6.6 Hz, 6H). 13C (75MHz, CHLOROFORM-d) δ 206.6, 162.6, 136.2, 130.1, 
119.6, 118.7, 118.4, 47.0, 25.5, 22.7. 
2-(3,3-dimethyl)butanoylphenol (5) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using phenol (1.42g, 15.0 mmol), t-butylacetyl chloride (2.01g, 15.0 mmol), and 
aluminum chloride (3.00g, 22.5mmol); yielded a pale oil (1.36 g, 47%). 1H NMR 
(300MHz, CHLOROFORM-d) δ 12.48 (s, 1H), 7.76 (d, J = 9.63 Hz, 1H), 7.46 (t, J = 8.49 Hz, 
1H), 6.98 (d, J = 9.60, 1H), 6.89 (t, J = 8.25 Hz, 1H), 2.85 (d, J = 6.87, 2H), 2.30 (sep, J = 
6.60 Hz, 1H), 1.02 (d, J = 6.60 Hz). 13C (75MHz, CHLOROFORM-d) δ 206.7, 162.6, 136.2, 
130.1, 119.6, 118.7, 118.5, 47.0, 25.5, 22.7. 
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2-(2-ethyl)butanoylphenol (6) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using phenol (1.75 g, 15.1 mmol), 2-ethylbutyryl chloride (2.01 g, 15.0 mmol), and 
aluminum chloride (2.40 g, 18 mmol); yielded a tan oil (1.27 g, 44%). 1H NMR (300MHz, 
CHLOROFORM-d) δ 12.71 (s, 1H), 7.81 (d, J = 9.6, 1H), 7.47 (t, J = 8.4 Hz, 1H), 6.99 (d, J = 
9.4 Hz, 1H), 6.90 (t, J = 8.1 Hz, 1H), 3.38-3.20 (m, 1H), 1.88-1.74 (m, 2H), 1.67-1.53 (m, 
2H), 0.89 (t, J = 7.1 Hz, 6H). 13C (75MHz, CHLOROFORM-d) δ 210.9, 163.0, 136.2, 129.9, 
119.8, 118.7, 118.7, 48.5, 25.1, 11.9. 
2-benzoyl-5-methylphenol (7) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using m-cresol (1.08 g, 10.0 mmol), benzoyl chloride (1.40 g, 10.0 mmol), aluminum 
chloride (2.08 g, 15.0 mmol); yielded a pale yellow solid (0.80 g, 38%).  1H NMR 
(300MHz, CHLOROFORM-d) δ 12.13 (s, 1H), 7.67-7.46 (m, 6H), 6.89 (s, 1H), 6.68 (d, J = 
9.0 Hz, 1H), 2.38 (s, 3H). 13C (75MHz, CHLOROFORM-d) δ 201.1, 163.5, 148.1, 138.1, 
133.5, 131.7, 129.0, 128.3, 120.0, 118.5, 116.9, 22.0. 
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2-benzoyl-4-bromophenol (8) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using p-bromophenol (0.37 g, 2.14 mmol), benzoyl chloride (0.30 g, 2.13 mmol), and 
aluminum chloride (0.57 g, 4.27 mmol); yielded a yellow solid (0.54 g, 91%).1H NMR 
(300MHz, CHLOROFORM-d) δ 11.93 (s, 1H), 7.70-7.51 (m,7H), 6.98 (d, J = 8.79 Hz, 1H). 
13C (100MHz, CHLOROFORM-d) δ 200.5, 162.1, 138.9, 137.2, 135.4, 132.4, 129.1, 128.6, 
120.5, 120.4, 110.2. 
2-(4’-fluorobenzoyl)-4-methylphenol (9) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using p-cresol (0.58 g, 5.4 mmol), 4-fluorobenzoyl chloride (0.84 g, 5.3 mmol), and 
aluminum chloride (0.98 g, 7.5 mmol); yielded a yellow solid (0.92 g, 75%). 1H NMR 
(300MHz, CHLOROFORM-d) δ 11.70 (s, 1H), 7.74-7.69 (m, 2H), 7.34 (d, J = 7.4 Hz, 2H), 
7.20 (t, J = 8.8 Hz, 2H), 6.98 (d, J = 7.4 Hz, 1H), 2.27 (s, 3H).  13C (75MHz, CHLOROFORM-
d) δ 200.0, 164.9 (d, J = 253.3 Hz), 161.1, 137.4, 134.2 (d, J = 3.5 Hz), 132.8, 131.7 (d, J = 
9.2 Hz), 127.9, 118.7, 118.3, 115.5 (d, J = 21.9 Hz), 20.5. 
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2-(2-furanoyl)-4-methylphenol (10) 
 
The general procedure for the Friedel-Crafts/Fries Rearrangement was followed to scale 
using 2-furanoyl chloride (1.08 g, 10.00 mmol), p-cresol (1.31 g, 10.04 mmol), and 
aluminum chloride (2.00 g, 15.02 mmol); yielded a yellow solid (1.07 g, 53%).1H NMR 
(300MHz, CHLOROFORM-d) δ 11.88 (s, 1H), 8.04-8.03 (m,1H), 7.75 (m, 1H), 7.38 (d, J = 
4.0 Hz, 1H), 7.33 (dd, J = 8.5 Hz, 1H), 6.95 (d, J = 8.5 Hz, 1H), 2.35 (s, 1H). 13C (100MHz, 
CHLOROFORM-d) δ 184.9, 161.3, 152.0, 147.1, 137.2, 131.1, 128.1, 120.8, 118.4, 118.2, 
112.4, 20.6. 
 2-benzoyl-6-ethoxyphenol (11) 
 
The general procedure for the direct coupling of salicylaldehydes with iodobenzene was 
followed to scale using 3-ethoxysalicylaldehyde (1.02 g, 6.13 mmol), Iodobenzene (2.45 
g, 12.0 mmol), palladium chloride (0.08 g, 0.30 mmol), lithium chloride (0.05g, 1.2 
mmol), sodium carbonate (1.23 g, 12.04 mmol); yielded a dark yellow oil (1.53 g, 82%). 
IR (ATR): 3058, 2980, 2929, 1623, 1599, 1575, 1445, 1249, 703 cm-1. 1H NMR (300MHz, 
CHLOROFORM-d) δ 12.18 (s, 1H), 7.69 (d, J = 6.3 Hz, 2H), 7.59 (t, 5.49 Hz, 1H), 7.50 (t, J = 
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5.5, 2H), 7.18 (d, J = 6.0, 1H), 7.10 (d, J = 5.2, 1H), 6.80 (t, J = 6.0, 1H), 4.16 (q, J = 5.2 Hz, 
2H), 1.51 (t, J = 5.2 Hz, 3H). 13C (75MHz, CHLOROFORM-d) δ 201.7, 153.6, 148.2, 138.0, 
131.9, 129.2, 128.2, 124.9, 119.4, 118.5, 117.9, 64.8, 14.8 
2-benzoyl-4-chlorophenol (12) 
 
The general procedure for the direct coupling of salicylaldehydes with iodobenzene was 
followed to scale using 5-chlorosalicylaldehyde (1.01 g, 6.45 mmol), iodobenzene (2.65 
g, 13.0 mmol), palladium chloride (0.055 g, 0.31 mmol), lithium chloride (0.051g, 1.3 
mmol), sodium carbonate (1.38 g, 12.98 mmol); yielded a yellow solid (0.84 g, 56%). 1H 
NMR (300MHz, CHLOROFORM-d) δ 11.91 (s, 1H), 7.69-7.43 (m, 7H), 7.05-7.02 (m, 1H).  
13C (75MHz, CHLOROFORM-d) δ 200.6, 161.7, 137.2, 136.2, 132.4, 129.1, 128.6, 123.4, 
120.1, 119.7. 
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3.1 Introduction 
Numerous natural products have been identified as potential therapeutic agents 
and play important roles in modern drug discovery.13 These compounds are often 
classified as primary or secondary metabolites. Primary metabolites serve as vital 
components in structure and function often exerting effect within the cell or organism 
and secondary metabolites have a variety of supporting roles. Some roles are not well 
understood and many others seem to be present to elicit response in other organisms, 
regulating interactions between these organisms. A substantial portion of modern 
medicines have originated from natural product compounds.14 The idea of producing 
molecules based on common structural themes found in natural products that bind with 
high affinity to a variety of unrelated protein receptors has become a fundamental 
principal guiding the drug discovery process. These structural themes have been termed 
“privileged medicinal scaffolds” and a number of these scaffolds are present in many 
commercially available drugs. Often these scaffolds consist of a heterocyclic ring system 
possessing functionalities with specific orientation to allow appropriate recognition at 
target receptors. Simple and efficient methodologies that produce the various 
functionalized versions of these scaffolds are highly desirable for preparation of large 
natural product-like libraries that can be assessed for potential therapeutic activity.  
Elinson et al. have identified the 2-amino-4H-chromene core as one such medicinally 
privileged scaffold. This structure is shown in Figure 3.1.10a  
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Figure 3.1 2-amino-4H-chromene medicinal scaffold 
 
3.2 Background for HTS Identification of Medicinally Relevant Compounds 
 Common chemotherapeutic agents used in modern cancer treatments are 
frequently recognized by cell growth inhibition assay. Species found to be active in this 
type of assay are classified as cytostatic or cytotoxic. Substances considered cytotoxic 
are further classified by their mode of action. A necrotic mode of action is a general 
term for an unspecific type of cell death resulting from traumatic acute injury, while 
induced apoptosis occurs by the careful regulation of events that result in the 
termination of the cell. The natural apoptotic regulation of cell proliferation is found to 
be altered in many types of cancer cells. Modern cytotoxic agents considered clinically 
relevant act primarily through the induction of apoptosis.17f Prevailing proapoptotic 
cancer treatments target tubulin which is a small family of proteins that make up 
microtubules a major component of the cytoskeletal framework responsible for cell 
structure, movement, and mitotic division. Examples of agents that target tubulin are 
the taxanes (Taxol and Taxotere) and the Vinca alkaloids (Vincristine, Vinblastine, and 
Vinorelbine). Effector caspases that cleave a variety of proteins have been determined 
to play essential roles in apoptotic cell death.17e Cai et al. have developed caspase 
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substrates that fluoresce when cleaved. This has allowed them to develop a high 
throughput screening assay to identify potential proapoptotic compounds.17g 
3.3 Applications of Chromene Compounds 
The Chromene moiety is found in a large number of natural products that are 
present in many different kinds of plants with varying biological activities and have long 
been known to prevent or treat disease. Among the many classes of compounds that 
contain this subunit are alkaloids, flavonoids, tocopherols, and anthocyanins. Many 
synthetic analogs containing the chromene moiety are now produced as 
pharmaceuticals for their antifungal and antimicrobial properties.12 Compounds of 
particular interest are shown in Figure 3.2. These molecules have been recognized for 
their potential treatment of diseases such as rheumatoid or psoriatic arthritis and 
cancer.10b Each of the compounds shown in Figure 3.2, represent excellent starting 
points for the design of synthetic libraries to be scrutinized for biological activity, and 
are the types of frameworks accessible through the methods optimized by our group.  
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   Figure 3.2 Biologically Active Chromene Compounds 
Through the high throughput screening fluorescent caspase substrates 
mentioned above Kemnitzer et al. have identified aryl substituted 4H-chromene 
compounds like compound A (Figure 3.2) as potent apoptosis inducers and have since 
prepared libraries of compounds based on SAR studies.17b Compound B (Figure 3.2) has 
also been identified by fluorescent caspase high throughput screening methods as an 
apoptosis inducing agent. It has also been reported to be a good antagonist for the  
Bcl-2/Bak family of proteins . It has been shown that overexpression of the Bcl-2 
protein leads to the protection of cancer cells from apoptotic regulatory events.28,29                    
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    Benzopyranopyridine compounds similar to compound C (Figure 3.2) have 
been shown to modify production of the proinflammatory TNFα (tumor necrosis factor 
alpha) protein.27 The TNFα protein is a type of cytokine able to induce apoptotic cell 
death which produces inflammation and inhibits tumorgenesis. Figure 3.3 shows the 
structure of Amlexanox, which is currently a commonly prescribed drug for its 
antiallergenic and topical antiulcer effects.15 
 
Figure 3.3 Amlexanox 
3.4 Literature Methods  
Kemnitzer et al. extensively report the synthesis of 4-aryl substituted 2-amino-3-
cyano-4H-chromenes (Method A, Scheme 3.1).17 Many of these compounds were 
synthesized in a three component reaction consisting of a slight excess of the 
corresponding phenol derivative with respect to the aryl aldehyde, 1 equivalent 
malononitrile with respect to the phenol, and 2 molar equivalents of piperidine all in 
solution with ethanol. Sometimes these reactions were carried out at reflux or at room 
temperature with reaction times usually varying from 12-24 hours. Similarly, these types 
of compounds are produced essentially following the same procedure in a stepwise 
process allowing the aryl aldehyde to condense with malononitrile creating the 
benzylidene product and then reacting this species with the phenol.17b These reactions 
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appear to be limited by the necessity for the presence of strong activating groups on the 
phenol compound.  Similarly, the three component method is described in high yields by 
Kidwai et al. using equimolar amounts of aryl aldehyde, resorcinol, and malononitrile in 
aqueous potassium carbonate under microwave irradiation (Method B, Scheme 3.1).18  
 
Scheme 3.1 Three Component Production of 4-substituted 2-amino-3-cyano-4H-chromenes
 
 Cai et al. have described the preparation of 3-Cyano-2-imino-4-phenyl-2H-
chromene by reaction of malononitrile with 2-hydroxybenzophenone at a 1:1 mol ratio 
in ethanol catalyzed by a half molar equivalent of piperidine (Method C, Scheme 3.2).20 
A similar reaction was reported by Junek using a 1:1 malononitrile: 2’-
hydroxyacetophenone with 10% aqueous sodium hydroxide or sodium ethoxide solution 
in ethanol (Method D, Scheme 3.2).16   
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Scheme 3.2 Malononitrile Condensation with 2’-Hydroxyphenylketones
 
 For the preparation of 4H-chromene compounds with deactivating substituents 
Kemnitzer et al. chose diazotization of the corresponding 7-amino (Ia) compound and 
nucleophillic substitution to produce a halogenated product (IIIa). 17a To avoid 
interference with the diazotization process the 2-amino group was oxidized with 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)  to the imino-2H-chromene (IIa) and after 
halogenation reduced back to the 4H-chromene (I) with sodium borohydride (Scheme 
2.3). This is the only instance we have seen sodium borohydride used in the preparation 
of 4H-chromenes. The lengthy and low yielding (10-14%) conversion of NH2 to Cl or Br 
further justifies the use of synthetic methods developed by our group. 
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Scheme 3.3 Oxidation/Reduction of 2H/4H-Chromenes
 
3.5 Results and Conclusions 
 The one-pot methods developed by Tayyari et al. were expanded and applied 
with modification to prepare 4H-chromenes substituted at the 4 position. The 
procedure was modified by the addition of aqueous sodium hydroxide solution during 
the condensation step and a series of 4H-chromene compounds were produced. This 
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study has shown that the methods developed by our group could be expanded to 
produce a new series of potentially useful compounds. Some of the compounds we 
produced suffered from relatively low yields. A particular example being the isopropyl 
derivative in which we were able to isolate 23% of the expected product (Table 3.1). In 
this case were able to identify a second major product through mass spectral and 
1HNMR to be a substituted benzopyranopyridine. These types of compounds were 
observed to be the major product in earlier experiments using strongly activated 
salicylaldehydes and two equivalents of malononitrile. At that time two equivalents of 
malononitrile were necessary to facilitate the formation of the intermediate (IIIa, Figure 
3.4). 
 
Figure 3.4 Intermediates for One-Pot Method 
The ratio of reactants for the production of the 4-alkyl or 4-aryl derivatives was deemed 
most suitable to be one molar equivalent of malononitrile to one molar equivalent 2’-
hydroxyketone. The intermediates for these reactions were continually shown to be of 
the 2-imino-2H-chromene type (IIIb, Figure 3.4). One of the goals of the project was to 
incorporate gradually more sterically hindered groups to probe the tolerance for such 
groups during the initial condensation. Our assessment is that the sterically hindered 
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ketone carbonyl is less available for the reaction with malononitrile and lower reactivity 
results. This lag potentially allows for more opportunity for the competing reaction to 
become more prevalent as evidenced by the isolation of the major side product. Future 
inquiries should involve the adjustment of reaction conditions such that the desired 
products could be prepared preferentially.  Our hopeful expectation is that through 
collaborative effort, some of the molecules we have prepared will show promising 
biological activity. This will guide the future of the project allowing us to focus on 
functionalities that improve activity and justify further optimization of the current 
methods.  Table 3.1 describes each of the products and reaction times. The compounds 
prepared demonstrate the importance of this methodology in its ability to produce 
functionalities of interest for the possible treatment and prevention of disease. 
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Table 3.1  Substituted 4-H Chromene products 
  
 
 
 
R1 R2 R3 R4 Time (h) Product Yield (%) 
Methyl H H H * 13 71 
Methyl Bromo H H * 14 52 
Methyl Nitro H H * 15 Low 
Ethyl H H H * 16 76 
Propyl H H H 3 17 25 
Propyl Methyl H H 0.75 18 68 
Isopropyl H H H 2.5 19 23 
Isobutyl H H H 1 20 57 
Neopentyl H H H 1 21 53 
Phenyl H H H 3.5 22 58 
Phenyl H H Ethoxy 0.5 23 75 
Phenyl H Methyl H 1 24 57 
Phenyl Bromo H H 1 25 55 
4-Fluorophenyl Methyl H H 1 26 65 
Phenyl Chloro H H 1 27 64 
2-Furanyl Methyl H H 1 28 51 
*Prepared by modified condensation procedure method. Precipitate usually 
formed immediately upon cooling. 
40 
 
3.6 General Experimental 
Analytical thin-layer chromatography (TLC) was performed using Baker-Flex silica 
gel IB-F plates and visualized using UV lamp or basic KMnO4 (2.3 g KMnO4, 15 g K2CO3, 
1.9 mL 2.5M NaOH in 300 mL DI H2O). Column chromatography was performed using 
silica gel (35-70mm, 6nm pore) from Acros. Infrared spectra were recorded on a Perkin-
Elmer Spectrum 100 FT-IR spectrometer using an ATR accessory with a diamond 
element. Proton (1H NMR) and carbon-13 nuclear magnetic resonance (13C NMR) 
spectra were recorded on JEOL Eclipse multinuclear FT-NMR spectrometer (400 MHz or 
300 MHz). Chemical shifts are reported from referenced values for CDCl3 (
1H NMR = 
7.26ppm, 13C = 77.16 ± 0.06ppm), ACETONE-d6 (
1H NMR = 2.05ppm, 13C = 29.84 ± 
0.01ppm), and DMSO-d6 (
1H NMR = 2.50ppm, 13C = 39.52 ± 0.01ppm).19 Purchased 
chemicals were used without further purification, prepared materials were purified by 
column chromatography or recrystallization prior to use. 
Representative Procedure 
 2’-Hydroxyphenylketone (1 mmol) was dissolved (by heating if a solid) in 95% 
ethanol (1-2 mL) then malononitrile (1 mmol) and 10% aqueous sodium hydroxide (5-6 
drops). The solution was stirred at room temperature until precipitation was complete. 
If the precipitate did not form at 1 hour, DI H2O (<1mL) was added drop-wise (to 
facilitate precipitation) and stirring was allowed to continue until precipitation was 
complete. Times for the condensation step varied and are recorded in Table 3.1.  
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Additional 95% ethanol (5 mL) was then added and the mixture was cooled on an ice 
bath to 0 °C. The cooled mixture continued to stir while sodium borohydride  
(1 mmol)was added. The reduction step was usually complete at 4 hours but was often 
left overnight out of convenience and to ensure completion of the reaction. DI H2O was 
added (10 mL) to quench the reaction and precipitate the product, and the mixture 
cooled on an ice bath to complete precipitation. The solid was isolated by vacuum 
filtration, washed with cold DI H2O, and dried.  
-A slightly modified procedure was used in early experiments which incorporated 
heating the solution of 2-hydroxyphenylketone, malononitrile, and 10% aqueous sodium 
hydroxide in 95% ethanol to 70 °C for 1 minute then cooling to room temperature. The 
precipitate formed immediately upon cooling and the remainder of the process was as 
described in the representative procedure. This variation did not prove advantageous 
over the course of the study and was discontinued. This procedure will be referred to as 
the modified procedure. 
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3.7 Experimental Data 
2-Amino-3-cyano-4-methyl-4H-chromene (13) 
 
The modified procedure was followed using  2’-hydroxyacetophenone (1.365 g, 10.0 
mmol), malononitrile (0.639 g,9.7 mmol), and sodium borohydride (0.364 g, 9.6 mmol); 
yielded an off white solid (1.778 g, 71%); mp 124-125 °C. IR (ATR): 3436, 3330, 3244, 
3212, 3063, 2968, 2928, 2864, 2181, 1652, 1607, 1577, 1405, 969, 754 cm-1. 1H NMR 
(300MHz, ACETONE-d6) δ 7.30 (d, J = 7.41, 1H), 7.25-7.20 (m, 1H), 7.16-7.11 (m, 1H), 
6.96 (d, J = 7.95 Hz, 1H), 6.00 (s, 2H), 3.63 (q, J = 6.57 Hz, 1H), 1.38 (d, J = 6.87, 3H). 13C 
NMR (75 MHz, ACETONE- d6) δ 160.2, 148.9, 128.3, 127.9, 125.2, 124.7, 119.5, 116.1, 
58.5, 24.4. 
2-Amino-6-bromo-3-cyano-4-methyl-4H-chromene (14) 
 
The modified procedure was followed using 5-bromo-2-hydroxyacetophenone (0.461g, 
2.14 mmol), malononitrile (0.141 g, 2.13 mmol), an] sodium borohydride (0.081 g, 2.14 
mmol); yielded a white solid (0.291 g, 52%); mp 137-138°C. IR (ATR) 3443, 3320, 3286, 
3236, 3198, 2977, 2962, 2927, 2866, 2192, 1664, 1604, 1571, 1398, 817 cm-1.1H NMR 
(400MHz, CHLOROFORM-d) δ 7.30-7.27 (m, 2H), 6.82 (d, J = 9.16 Hz, 1H), 4.57 (s, 2H), 
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3.63 (q, J = 6.60 Hz, 1H), 1.43 (d, J = 6.60, 3H). 13C NMR (100 MHz, CHLOROFORM-d) δ 
159.3, 147.8, 131.0, 127.0, 119.8, 118.2, 117.5, 60.7, 29.3, 24.8. 
2-Amino-3-cyano-4-methyl-6-nitro-4H-chromene (15) 
 
The modified procedure was followed using 5-nitro-2-hydroxyacetophenone (0.090 g, 
0.54 mmol), malononitrile (0.053 g, 0.80 mmol), and sodium borohydride (0.081 g, 0.57 
mmol); yielded solid (low yield).  1H NMR (400MHz, DMSO-d6) δ 8.26-8.25 (m, 1H), 8.13-
8.09 (m, 1H), 7.23-7.20 (m, 1H), 7.05 (s, 2H), 3.75 (q, J = 8.8 Hz, 1H), 1.35 (d, J = 8.8 Hz, 
3H). 
2-Amino-3-cyano-4-ethyl-4H-chromene (16) 
 
The modified procedure was followed using  2’-hydroxypropiophenone (0.755 g, 5.0 
mmol), malononitrile (0.300 g, 4.5 mmol), and sodium borohydride (0.187 g, 4.9 mmol); 
yielded a solid (0.678 g, 76%); mp 77-78 °C. IR (ATR): 3456, 3330, 3279, 3215, 3049, 
2976, 2925, 2879, 2183, 1649, 1606, 1577, 1409, 1188, 755 cm-1. 1H NMR (300MHz, 
ACETONE-d6) δ 7.26-7.21 (m, 2H), 7.16-7.12 (m, 1H), 6.96 (d, J = 8.1Hz, 1H), 6.05 (s, 1H), 
3.62 (t, J = 4.8, Hz, 1H), 1.77-1.70 (m, 2H), 0.75 (t, J = 5.5 Hz, 3H). 13C NMR (100 MHz, 
ACETONE-d6) δ 162.2, 150.9, 129.1, 128.6, 125.4, 124.4, 120.5, 116.6, 56.7, 36.6, 31.2, 
8.9.  
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2-Amino-3-cyano-4-propyl-4H-chromene (17) 
 
Representative procedure followed to scale with 2’-hydroxybutaphenone (0.082 g, 0.52 
mmol), malononitrile (0.038 g, 0.58mmol), and sodium borohydride (0.020g, 0.53 
mmol); yielded a solid (0.026 g, 25%); mp 67-68 °C. IR (ATR) 3429, 3333, 3200, 3044, 
2955, 2927, 2870, 2187, 2179, 1647, 1603, 1578, 1412, 1221, 747 cm-1.1H NMR 
(300MHz, ACETONE-d6) δ 7.28-7.20 (m, 2H), 7.14 (t, J = 7.4 Hz, 1H), 6.96 (d, J = 8.2 Hz, 
1H), 6.04 (s, 2H), 3.60 (t, J = 4.9 Hz, 1H), 1.71-1.60 (m, 2H), 1.42-1.27 (m, 1H), 1.22-1.05 
(m, 1H), 0.88-0.84 (t, J = 7.4 Hz, 3H).13C NMR (100 MHz, ACETONE-d6) δ 162.1, 150.8, 
129.1, 128.6, 125.4, 125.2, 120.61, 116.7, 57.4, 41.5, 35.8, 18.7, 14.3. 
2-Amino-3-cyano-6-methyl-4-propyl-4H-chromene (18) 
 
Representative procedure followed to scale with 2-hydroxy-5-methylbutaphenone 
(0.091 g, 0.51 mmol), malononitrile (0.035 g, 0.53 mmol), and sodium borohydride 
(0.029 g, 0.44 mmol); yielded a white solid (0.077g, 68%); mp 139-149 °C. IR (ATR): 3403, 
3326, 3243, 3211, 2955, 2928, 2872, 2184, 1648, 1612, 1588, 1405, 1221, 808 cm-1. 1H 
NMR (300MHz, ACETONE-d6) δ 7.07-7.02 (m, 2H), 6.85 (d, J = 8.0 Hz, 1H), 5.99 (s, 1H), 
3.56 (t, J = 5.2 Hz, 1H), 2.29 (s, 3H), 1.72-1.60 (m, 2H), 1.44-1.27 (m, 1H), 1.22-1.05 (m, 
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1H), 0.86 (t, J = 7.41 Hz, 3H). 13C NMR (75 MHz, ACETONE-d6) δ 162.3, 148.7, 134.9, 
129.3, 129.1, 124.8, 120.7, 116.5, 57.7, 41.5, 35.8, 20.7, 18.7, 14.3. 
2-Amino-3-cyano-4-isopropyl-4H-chromene (19) 
 
Representative procedure followed to scale with 2-t-butanoylphenol (0.081g, 0.49 
mmol), malononitrile (0.038 g, 0.58 mmol), and sodium borohydride (0.028 g, 0.74 
mmol); yielded a white solid (0.024 g, 23%); mp 142-143 °C. IR (ATR): 3410, 3325, 3208, 
2965, 2934, 2901, 2867, 2181, 1638, 1608, 1578, 1411, 745 cm-1. 1H NMR (300MHz, 
CHLOROFORM-d) δ 7.24-7.17 (m, 1H), 7.14-7.11 (m, 2H), 6.96 (d, J = 8.0 Hz, 1H), 4.58 (s, 
2H), 3.45 (d, J = 3.6 Hz, 1H), 2.01-1.91 (m, 1H), 0.95 (d, J = 6.9 Hz, 3H), 0.81 (d, J = 6.6 Hz, 
3H). 13C NMR (75 MHz, CHLOROFORM-d) δ 161.7, 150.4, 128.8, 127.9, 124.8, 123.5, 
121.1, 116.1, 57.1, 41.8, 37.0, 19.2, 18.0. 
2-Amino-3-cyano-4-isobutyl-4H-chromene (20) 
 
Representative procedure followed to scale with 2-isovaleroylphenol (0.086 g, 0.48 
mmol), malononitrile (0.034 g, 0.51mmol), and sodium borohydride (0.026 g, 0.68 
mmol); yielded a off white solid (0.064 g, 57%); mp 108-108.5 °C. IR (ATR): 3425, 3327, 
3236, 3206, 2955, 2924, 2868, 2180, 1640, 1607, 1577, 1409, 1224, 759 cm-1. 1H NMR 
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(300MHz, ACETONE-d6) δ 7.24 (t, J = 7.7 Hz, 2H), 7.14 (t, J = 7.4 Hz, 1H), 6.98 (d, J = 8.3 
Hz, 1H), 6.07 (s, 2H), 3.57 (t, J = 6.30 Hz, 1H), 1.90-1.77 (m, 1H), 1.60-1.40 (m, 2H), 0.97 
(d, J = 6.3 Hz, 3H), 0.86 (d, J = 6.6 Hz, 3H). 13C NMR (75 MHz, ACETONE-d6) δ  162.3, 
150.7, 129.2, 128.5, 126.5, 125.4, 120.9, 116.9, 58.0, 50.2, 34.4, 25.4, 23.5, 22.9. 
2-Amino-3-cyano-4-neopentyl-4H-chromene (21) 
 
Representative procedure followed to scale using 2-(3,3-dimethyl)butanoylphenol 
(0.115 g, 0.60 mmol), malononitrile (0.041 g, 0.62 mmol), and sodium borohydride 
(0.020 g, 0.53 mmol); yielded a yellow-white solid (0.076 g, 53%); mp 100-101 °C. IR 
(ATR): 3458, 3319, 3225, 3196, 2953, 2902, 2865, 2187, 1636, 1611, 1599, 1576, 1417, 
754 cm-1. 1H NMR (300MHz, ACETONE-d6) δ 7.30-7.20 (m, 2H), 7.14 (t, J = 7.4 Hz, 1H), 
6.99 (d, J = 7.9 Hz, 1H), 6.09 (s, 2H), 3.59 (t, J = 5.8 Hz, 1H), 1.64-1.55 (m, 2H), 0.98 (s, 
9H). 13C NMR (75 MHz, ACETONE-d6) δ 162.9, 151.0, 128.9, 128.7, 128.3, 125.6, 121.2, 
116.9, 59.8, 54.4. 
2-Amino-3-cyano-4-phenyl-4H-chromene (22) 
 
Representative procedure followed to scale using 2-hydroxybenzophenone (0.224 g, 
1.10 mmol), malononitrile (0.073 g, 1.11 mmol), and sodium borohydride (0.042 g, 1.11 
47 
 
mmol); yielded a white solid (0.156 g, 58%); mp 206.0-206.5 °C. IR (ATR): 3444, 3326, 
3241, 3204, 3027, 2883, 2189, 1647, 1609, 1579, 1405, 744 cm-1. 1H NMR (400MHz, 
ACETONE-d6) δ 7.34-7.31 (m, 2H), 7.28-7.20 (m, 4H), 7.09-7.04 (m, 3H), 6.18 (s, 2H), 4.79 
(s, 1H) 
2-Amino-3-cyano-8-ethoxy-4-phenyl-4H-chromene (23) 
 
Representative procedure followed to scale using 2-benzoyl-6-ethoxyphenol (0.256 g, 
1.06 mmol), malononitrile (0.067 g, 1.01 mmol), and sodium borohydride (0.038 g, 1.00 
mmol); yielded a slightly pink-white solid (0.232 g, 75%); mp 199.5-200.5 °C. IR (ATR): 
3474, 3288, 3324, 3242, 3177, 1H NMR (400MHz, ACETONE-d6) δ 7.34-7.20 (m, 5H), 
6.98-6.89 (m, 2H), 6.62 (d, J = 7.68, 1H), 6.19 (s, 2H), 4.75 (s, 1H), 4.12 (q, J = 6.96 Hz, 
2H), 1.41 (t, J = 6.96 Hz, 3H). 13C (100MHz, CHLOROFORM-d) δ 159.4, 147.0, 144.8, 
138.7, 128.9, 128.0, 127.4, 124.8, 124.1, 121.0, 120.0, 111.6, 64.8, 60.9, 41.3, 14.9 
2-Amino-3-cyano-7-methyl-4-phenyl-4H-chromene (24) 
 
Representative procedure followed to scale using 2-benzoyl-5-methylphenol (0.102 g, 
0.48 mmol), malononitrile (0.033 g, 0.50 mmol), and sodium borohydride (0.020 g, 0.53 
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mmol); yielded a white solid (0.071 g, 57%); mp 207-208 °C. IR (ATR): 3449, 3324, 3230, 
3202, 3026, 2924, 2187, 1646, 1626, 1607, 1572, 1404, 698 cm-1. 1H NMR (300MHz, 
CHLOROFORM-d) δ 7.33-7.17 (m, 5H), 6.85-6.82 (m, 3H), 4.70 (s, 1H), 4.55 (s, 2H), 2.31 
(s, 3H). 13C NMR (75 MHz, ACETONE-d6) δ 161.1, 149.5, 147.0, 139.2, 130.1, 129.5, 
128.6, 127.7, 126.5, 121.5, 120.3, 117.2, 59.3, 41.9, 20.9  
2-Amino-6-bromo-3-cyano -4-phenyl-4H-chromene (25) 
 
Representative procedure followed to scale using 2-benzoyl-4-bromophenol (0.135 g, 
0.49 mmol), malononitrile (0.034 g, 0.51 mmol), and sodium borohydride (0.019 g, 0.50 
mmol); yielded a solid (0.085 g, 55%); mp 215.0-216.0 °C. IR (ATR) 3456, 3312, 3275, 
3227, 3192, 3065, 3023, 2199, 1643, 1603, 1570, 1218, 825, 700 cm-1. 1H NMR (400MHz, 
ACETONE-d6) δ 7.41-7.23 (m, 7H), 7.03 (d, J = 8.52, 1H), 6.28 (s, 2H), 4.82 (s, 1H). 
13C 
NMR (75 MHz, ACETONE-d6) δ 160.9, 149.0, 146.2, 132.9, 132.0, 129.7, 128.6, 128.1, 
127.1, 119.8, 119.3, 117.3, 59.1, 41.9. 
 
 
 
 
 
 
49 
 
2-Amino-3-cyano-4-(4-fluorophenyl)-6-methyl-4H-chromene (26) 
 
Representative procedure followed to scale using 2-(4’-fluorobenzoyl)-4-methylphenol 
(0.105 g, 0.49 mmol), malononitrile (0.034 g, 0.51 mmol), and sodium borohydride 
(0.019 g, 0.50 mmol); yielded a pale pink solid (0.089 g, 65%); mp 172-173 °C. IR (ATR): 
3436, 3324, 3211, 3044, 2919, 2199, 1647, 1614, 1605, 1496, 1401, 1219, 809 cm-1.1H 
NMR (300MHz, CHLOROFORM-d) δ 7.19-7.14 (m, 2H), 7.04-6.89 (m, 4H), 6.73 (s, 1H), 
4.69 (s, 1H), 4.60 (s, 2H), 2.21 (s, 3H).  13C NMR (75 MHz, ACETONE-d6) δ 162.1 (d, J = 
242.1 Hz), 159.4, 146.6, 140.7, 134.9, 129.8, 129.6 (d, J = 8.1 Hz), 129.2, 122.3, 119.9, 
116.1 (d, J = 21.9 Hz), 115.7, 60.8, 40.4, 20.8.  
2-Amino-6-chloro- 3-cyano-4-phenyl-4H-chromene (27) 
 
Representative procedure followed to scale using 2-benzoyl-4-chlorophenol (0.116 g, 
0.50 mmol), malononitrile (0.036 g, 0.54 mmol), and sodium borohydride (0.020 g, 0.53 
mmol); yielded a solid (0.090 g, 64%); mp 206-207 °C. IR (ATR): 3458, 3311, 3275, 3228, 
3193, 3066, 3024, 2198, 1642, 1604, 1574, 1411, 826 cm-1. 1H NMR (300MHz, ACETONE-
d6) δ 7.37-7.23 (m, 6H), 7.12-7.07 (m, 2H), 6.28 (s, 2H), 4.82 (s, 1H). 
13C NMR (100 MHz, 
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ACETONE-d6) δ 160.1, 147.7, 145.4, 129.1, 128.9, 128.2, 127.8, 127.3, 125.8, 119.0, 
118.2, 58.2, 41.1. 
2-Amino-3-cyano-4-furanyl-6-methyl-4H-chromene (28) 
 
Representative procedure followed to scale using 2-furanoyl-4-methylphenol (0.140 g, 
0.70 mmol), malononitrile (0.048 g, 0.73 mmol), and sodium borohydride (0.029 g, 0.77 
mmol); yielded a pale blue-green solid (0.089 g, 51%); mp 191.0-191.5 °C. IR (ATR): 
3440, 3327, 3241, 3208, 2929, 2186, 1647, 1609, 1587, 1407, 736 cm-1. 1H NMR 
(300MHz, CHLOROFORM-d) δ 7.33 (m, 1H), 6.99-6.90 (m, 2H), 6.88 (d, J = 8.22, 1H), 
6.30-6.29 (m, 1H), 6.16 (d, J = 4.04, 1H), 4.83 (s, 1H), 4.65 (s, 2H), 2.28 (s, 3H). 13C 
(75MHz, CHLOROFORM-d) δ 160.3, 155.7, 146.6, 142.4, 134.7, 129.3, 129.2, 119.8, 
119.7, 116.2, 110.3, 106.4, 57.4, 34.6, 20.7 
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4.1 Introduction 
 As noted above, the benzopyran subunit is well known as a biologically relevant 
functionality and the many variant classes of this structure have shown broad utility in 
agriculture and medicine. Similarly, the 4H-chromene moiety in particular is of interest 
for use as antifungal, antimicrobial, anti-inflammatory, and antitumor agents.12 
Specifically, ester functionalized 4-H chromenes have been hypothesized on the basis of  
computational protein binding data, to be capable of affecting apoptotic events.28 Since 
then various analogues have been produced and their activity documented. To further 
investigate the application of our one-pot production of 4H-chromenes, the substrates 
were expanded to include the reaction of salicylaldehydes with ethyl cyanoacetate or 
cyanoacetamide. Our products, generated through by this methodology, are anticipated 
to be biologically active, as the share many characteristics of known 4H-chromenes. 
These compounds have not been reported in the literature.    
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4.2 Applications of other 4H-Chromenes 
 
Figure 4.1 HA 14-1/ sHA 14-1 
 The structure shown above in Figure 4.1 is often referred to as HA 14-1 (IVa) and 
has been reported to be an antagonist for the Bcl-2 protein by competing for the 
binding site of the Bak protein. It has also been shown that overexpression of the Bcl-2 
proteins leads to the protection of cancer cells from apoptotic regulatory events.28,29  
This activity was first recognized by computationally screening nearly 200,000 
compounds for binding affinity to Bcl-2. High throughput screening confirmed inhibition, 
by demonstrating that at 50µM 90% of the HL-60 cells underwent apoptosis. This a 
somewhat high concentration in comparison with more recently discovered compounds 
but indicates proof of concept.32 Doshi et al. were able to show that HA 14-1 was not 
stable in vitro and was decomposed into ethylcyanoacetate (IVc), 5-
bromosalicylaldehyde (IVd), and both the ester (IVf) and carboxylic acid (IVe) substituted 
coumarin derivatives. The decomposition products are shown in Figure 4.2. 
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Figure 4.2 HA 14-1 In vitro Decompostion Products 
They have also shown that none of these compounds alone or together were 
able to induce apoptosis to the extent of HA 14-1. The mechanism of action seemed to 
be primarily through the generation of ROS (reactive oxygen species). This was 
illustrated by the profound reduction in cytotoxicity after the introduction of a ROS 
scavenger into the assay. This mode of action is the apparent result of the 
decomposition process and does not allow for Bcl-2 antangonist activity. The conclusion 
from this study was that a more stable version of the compound should be pursued such 
that it would resist degradation and allow for greater efficacy of the active parent 
compound.33 The result was the preparation of sHA 14-1 (IVb) shown in Figure 4.1 and 
justifies the continued exploration of related analogues. The general sequence for the 
preparation of this compound is shown in Scheme 4.5 of the next section. 
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  Through SAR studies the sHA 14-1 structure was determined to be a more stable 
and potent analogue than HA 14-1. Das et al. were able to further optimize these results 
and produce analogues that have shown to have much higher toxicity in a variety of 
cancer cell lines, without generating ROS and maintaining the lack of drug resistance 
and synergistic activity with other therapeutic agents that was characteristic of the 
predecessor compound.33    
4.3 Literature Methods for Preparation of Other 4H-Chromenes 
 Various methods exist for the preparation of ester functionalized 4H-Chromenes. 
Gree et al. reported that the reaction of 1 equivalent of 5-bromosalicylaldehyde with 2 
equivalents of ethyl cyanoacetate in ethanol in the presence of molecular sieves 
generated the product HA 14-1 in good yields (Scheme 4.1, Method A).29 In order to 
vary the substituents on the group attached to the chromene 4-position, they opted or 
were required to protect the salicylaldehyde phenol group to prevent cyclization prior 
to the Michael addtition step (Scheme 4.1, Method B).28 
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        Scheme 4.1 Preparation of ester functionalized 4H-Chromenes 
 
 
      Scheme 4.2 Electrocatalytic Condensation of Salicylaldehyde with Activated Methylene Compounds
 
Elinson et al. describe a similar reaction to produce the HA 14-1 compound using 
electrocatalysis with a 1:2 mixture of salicylaldehydes and ethyl cyanoacetate 
respectively in ethanol with sodium bromide. This sequence is shown in Scheme 4.2. 
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Scheme 4.3 Multicompontent preparation of ester functionalized 4H-Chromenes
 
 Jin et al. report the preparation of ester functionalized naphthopyran chromene 
derivatives in good to high yields by a multicomponent reaction mixture of 
benzaldehydes, ethyl cyanoacetate (or malononitrile), and 1- or 2-naphthol with HTMAB 
(Hexadecyltrimethylammonium bromide) in refluxing water.30 A representative example 
is depicted in Scheme 4.3. 
             
 Scheme 4.4 Further Multicomponent Preparation of Ester Functionalized 4H-Chromenes  
Likewise Kumar et al. report good to high yields for preparation of ester functionalized 
aryl substituted 4H-chromenes using a similar multicomponent reaction of phenols, 
ethyl cyanoacetate (or malononitrile), and benzaldehydes catalyzed with TiCl4 under 
solvent-free conditions at room temperature.31 This is depicted in scheme 4.4.  
 
58 
 
 
 
  Scheme 4.5 Reaction sequence for preparation of ester sHA 14-1 analogues 
 Scheme 4.5 depicts the preparation of sHA 14-1 analogues, the synthesis begins 
by formylation of 4-phenylphenol or Suzuki coupling of 5-bromosalicylaldehyde to 
phenylboronic acid. The resulting 5-phenylsalicylaldehyde is reacted with N,N-
dimethylacetamide and phosphorous oxychloride which upon treatment with 
bicarbonate gives coumarin. Coumarin is a good Michael acceptor and is able to react 
with ethyl cyanoacetate or malononitrile under varied conditions to give the sHA 14-1 
analogue.33                 
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4.4 Discussion and Conclusions 
 The reaction of salicylaldehyde with ethyl cyanoacetate and subsequent 
reduction with sodium borohydride produced the expected ethyl substituted 4H-
chromene. The reaction was quite consistent with the analogous reaction of 
malononitrile and salicylaldehyde although additional catalyst was necessary to enable 
the condensation. When these methods were applied to salicylaldehyde with 
cyanoacetamide the product upon reduction was shown not to be the amide 
substituted 4H-chromene deriviative.  The intermediate formed was isolated on several 
occasions and was consistently observed to be the 2-imino-2H-chromene-3-
carboxamide, after the sodium borohydride reduction the pyran ring would open to give 
the unexpected 2-cyano-3-(2-hydroxyphenyl)propanamide product.  The reaction was 
carried out with the more activated 3-ethoxysalicylaldehyde and the open form still 
resulted. Similarly, deactivated salicylaldehydes were reacted with ethyl cyanoacetate 
to explore the possibility that the products may be of the open form though the 4H-
chromene was produced for each of the substrates. Products are described in Table 4.1. 
Our assertion is that the methods outlined in this investigation allow for the preparation 
of multiple variations of the medicinally relevant 4H-chromene core. The ability to 
functionalize this core particularly at the 4-position with alkyl substituents easily allows 
for speculation that other variations are possible. To produce compounds less 
susceptible to degradation in vivo and yield greater efficacy. Also the simple production 
of the biologically active 4-aryl substituted chromenes with better reaction tolerance for 
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activating or deactivating substituents is also of great importance. It is our hope that 
collaborations with Eli Lilly & Co. will yield further insight into this investigation and 
guide future efforts.   
 
Form R R’ Product Yield (%) 
Cyclized 
(ester) 
H H 29 63 
H Cl 30 60 
Cl Cl 31 56 
Open 
(amide) 
H H 32 73 
H Cl 33 77 
Cl Cl 34 40 
Table 4.1 Ethylcyanoacetate/Cyanoacetamide One-Pot Products 
4.5 General Experimental 
Analytical thin-layer chromatography (TLC) was performed using Baker-Flex silica 
gel IB-F plates and visualized using UV lamp or basic KMnO4 stain (2.3g KMnO4, 15g 
K2CO3, 1.9mL 2.5M NaOH in 300mL DI H2O). Column chromatography was performed 
using silica gel (35-70mm, 6nm pore) from Acros. Infrared spectra were recorded on a 
Perkin-Elmer Spectrum 100 FT-IR spectrometer using an ATR accessory with a diamond 
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element. Proton nuclear magnetic resonance (1H NMR) spectra and carbon-13 nuclear 
magnetic resonance (13C NMR) spectra were recorded on a JEOL Eclipse spectrometer at 
400 MHz or 300 MHz and 100 or 75 MHz, respectively. Chemical shifts are reported 
downfield from referenced values for CDCl3 (
1H NMR = 7.26ppm, 13C = 77.16 ± 
0.06ppm), ACETONE-d6 (
1H NMR = 2.05ppm, 13C = 29.84 ± 0.01ppm), and DMSO-d6 (
1H 
NMR = 2.50ppm, 13C = 39.52 ± 0.01ppm).19 Purchased chemicals were used without 
further purification, prepared materials were purified by column chromatography or 
recrystallization prior to use. 
Representative Procedure for the Preparation of Ethyl 2-Amino-4H-Chromene-3-
Carboxylates 
Salicylaldehyde (1 mmol) was added to the reaction vessel followed by 
Ethylcyanoacetate (1 mmol) then 95% ethanol (1mL) and a catalytic amount of 
piperidine (approximately 2-3 drops) or alumina (Al2O3)
*. The solution was stirred at 
room temperature until precipitation was complete. Additional 95% ethanol was added 
(3-4 mL) and the mixture was cooled on an ice bath to 0 °C. To the cooled mixture 
sodium borohydride was added (1 mmol) and the reaction was typically finished by 4 
hours but often allowed to stir overnight for convenience and to ensure completion. DI 
H2O was added (10 mL) to quench the reaction and precipitate the product. This mixture 
was cooled on ice bath to complete precipitation and solid was separated by vacuum 
filtration and washed with DI H2O.  
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*When Al2O3 is used as the catalyst the reaction mixture is hot filtered prior to the 
reduction step, the solid alumina collected in the filter is then washed with boiling 
ethanol. The ethanol mother liquor is cooled and subjected to the reduction step (if the 
intermediate imino 2H-chromene was desired DI H2O was added to facilitate 
precipitation). 
Procedure for the Preparation of 2-Cyano-3-(2-Hydroxyphenyl)Propanamides 
Cyanoacetamide (1 mmol) was dissolved (with heating) in 95% ethanol (4-5 mL) 
and to this solution was added salicylaldehyde (1 mmol) and a catalytic amount of 
piperidine (approximately 2-3 drops). The solution was stirred at room temperature 
until precipitation was complete. Additional 95% ethanol was added (3-4 mL) and the 
mixture was cooled on an ice bath to 0 °C. To the cooled mixture sodium borohydride 
was added (1 mmol) and the reaction was typically complete at 4 hours. DI H2O was 
added (10 mL) to quench the reaction and precipitate the product. This mixture was 
cooled on ice bath to complete precipitation and solid was separated by vacuum 
filtration and washed with DI H2O.  
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4.6 Data 
ethyl 2-amino-4H-chromene-3-carboxylate (29) 
 
Representative procedure followed to scale with salicylaldehyde (0.623g, 5.10 mmol), 
ethylcyanoacetate (0.585g, 5.17 mmol), and sodium borohydride (0.181 g, 4.78 mmol); 
yielded a solid (0.682g, 63%); mp 76-77 °C. IR (ATR): 3410, 3298, 2987, 2901, 2838, 
1737, 1670, 1607, 1521, 1488, 1457, 1226, 752 cm-1. 1H NMR (400 MHz, DMSO-d6) δ 
7.50 (s, 2H), 7.25-7.18 (m, 2H), 7.08 (t, J = 7.4 Hz, 1H), 6.96 (d, J = 7.9 Hz, 1H), 4.10 (q, J = 
7.2 Hz, 2H), 3.49 (s, 2H), 1.22 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, ACETONE-d6) δ 
170.0, 161.7, 150.7, 130.0, 128.3, 125.0, 122.8, 116.5, 71.8, 59.6, 23.9, 15.0. 
ethyl 2-amino-6-chloro-4H-chromene-3-carboxylate (30) 
 
Representative procedure followed to scale with 5-chlorosalicylaldehyde (0.497 g, 3.17 
mmol), ethylcyanoacetate (0.369 g, 3.26 mmol), and sodium borohydride (0.111 g, 2.93 
mmol); yielded a solid (0.482 g, 60%); mp 82-83°C. IR (ATR): 3471, 3330, 2980, 2907, 
2850, 1684, 1624, 1610, 1523, 1476, 1184, 1083, 809, 766 cm-1. 1H NMR (400 MHz, 
DMSO-d6) δ 7.53 (s, 2H), 7.35 (s, 1H), 7.26-7.23 (m, 1H), 6.99 (d, J = 8.4 Hz, 1H), 4.10 (q, J 
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= 5.2 Hz, 2H), 3.49 (s, 2H), 1.22 (t, J = 5.2 Hz, 3H). 13C NMR (100 MHz, ACETONE-d6) δ 
168.5, 160.3, 148.1, 128.7, 127.7, 127.4, 124.0, 117.4, 69.4, 58.8, 22.8, 14.6 
ethyl 2-amino-6,8-dichloro-4H-chromene-3-carboxylate (31) 
 
Representative procedure followed to scale with 5-chlorosalicylaldehyde (0.190 g, 1.00 
mmol), ethylcyanoacetate (0.113 g, 1.00 mmol), and sodium borohydride (0.040 g, 1.05 
mmol); yielded a solid (0.162 g, 56%); mp 122.5-123°C. IR (ATR): 3396, 3286, 2983, 2911, 
1685, 1628, 1520, 1459, 1408, 1281, 1198, 1184, 1031 cm-1. 1H NMR (300 MHz, DMSO-
d6) δ 7.60 (s, 2H), 7.52 (d, J = 2.2 Hz, 1H) 7.37 (d, J = 2.2 Hz, 1H), 4.10 (q, J = 7.1Hz, 2H), 
3.53 (s, 2H), 1.22 (t, J = 7.1Hz, 3H). 13C NMR (100 MHz, ACETONE-d6) δ 168.3, 159.7, 
144.2, 127.6, 127.4, 125.6, 120.8, 69.6, 58.9, 23.1, 14.6. 
2-cyano-3-(2-hydroxyphenyl)propanamide (32) 
 
Representative procedure followed to scale with salicylaldehyde (0.600 g, 4.9 mmol), 
cyanoacetamide (0.430 g, 5.11 mmol), and sodium borohydride (0.200 g, 5.28 mmol); 
yielded a solid (0.701 g, 73%); mp 154-155°C. IR(ATR): 3373, 3315, 3152, 2930, 2862, 
2811, 2252, 1691, 1605, 1423, 1227, 687 cm-1. 1H NMR (300 MHz, DMSO-d6) δ 9.63 (s, 
65 
 
1H), 7.81 (s, 1H), 7.46 (s, 1H), 7.11-7.06 (m, 2H), 6.82 (d, J = 7.32 Hz, 1H), 6.74 (t, J = 
7.28, 1H), 3.92 (t, J = 7.68, 1H), 3.04-2.97 (m, 2H).13C NMR (100 MHz, ACETONE-d6) δ 
167.7, 156.1, 132.0, 129.4, 124.0, 120.5, 118.8, 116.1, 38.3, 31.8. 
2-cyano-3-(3-ethoxy-2-hydroxyphenyl)propanamide (33) 
 
Representative procedure followed to scale with 3-ethoxysalicylaldehyde (0.843 g, 5.07 
mmol), cyanoacetamide (0.444 g, 5.28 mmol), and sodium borohydride (0.201 g, 5.31 
mmol); yielded a solid (0.901 g, 77%); mp 149.5-150°C. IR (ATR): 3443, 3323, 3032, 2976, 
2928, 2874, 2248, 1697, 1608, 1495, 1470, 1270, 1077, 729 cm-1.  1H NMR (400 MHz, 
DMSO-d6) δ 8.61 (s, 1H), 7.82 (s, 1H), 7.47 (s, 1H), 6.86 (d, J = 7.32, 1H), 6.73-6.68 (m, 
2H), 4.04 (q, J = 6.96, 2H), 3.89 (t, J = 6.96 1H), 3.08-2.97 (m, 2H), 1.35 (t, J = 6.96, 
3H).13C NMR (100 MHz, DMSO-d6) δ 166.4, 146.4, 144.6, 123.3, 122.3, 118.7, 118.6, 
112.0, 64.0, 37.2, 30.1, 14.7.  
2-cyano-3-(5-chloro-2-hydroxyphenyl)propanamide (34) 
 
Representative procedure followed to scale with 5-chlorosalicylaldehyde (0.156g, 1.00 
mmol), cyanoacetamide (0.088g, 1.33 mmol), and sodium borohydride (0.040 g, 1.05 
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mmol); yielded a solid (0.090 g, 40%); mp 140.5-141.5 °C. IR (ATR): 3381, 3178, 2249, 
1688, 1632, 1606, 1498, 1419, 1274, 1115, 807 cm-1. 1H NMR (400 MHz, DMSO-d6) δ 
9.97 (s, 1H), 7.81 (s, 1H), 7.50 (s, 1H), 7.17-7.11 (m, 6H), 6.84-6.81 (m, 2H), 3.97-3.92 (m, 
1H), 3.02-2.99 (m, 2H).13C NMR (100 MHz, DMSO-d6) δ 166.7, 155.0, 130.6, 128.5, 125.6, 
122.7, 118.9, 117.1, 37.4, 30.3. 
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